Yoshihiro Hatta
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 38
- Acute Myeloid Leukemia Research 29
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 25
- Oncology top 5%
-
- Lymphoma Diagnosis and Treatment 23
- Immunology top 5%
- T-cell and Retrovirus Studies 14
-
- Acute Lymphoblastic Leukemia research 27
-
- Eosinophilic Disorders and Syndromes 19
-
- Retinoids in leukemia and cellular processes 10
- Co-authors
- HP KoefflerNoriyoshi IriyamaMasao TomonagaSeisho TakeuchiJin TakeuchiCarl W. MillerRoberta MorosettiToshiyasu Hirama
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (18 papers)International Journal of Hematology (12 papers)British Journal of Haematology (6 papers)
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Yoshihiro Hatta
147 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 97
- Hematology 654
- Genetics 367
- Oncology 848
- Pathology and Forensic Medicine 414
- Immunology 456
Countries citing papers authored by Yoshihiro Hatta
This map shows the geographic impact of Yoshihiro Hatta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Hatta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Hatta more than expected).
Fields of papers citing papers by Yoshihiro Hatta
This network shows the impact of papers produced by Yoshihiro Hatta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Hatta. The network helps show where Yoshihiro Hatta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshihiro Hatta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 2 | |
| 13 | 2018 | 2 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 1 | |
| 16 | 2014 | 7 | |
| 17 | 2011 | 48 | |
| 18 | Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line. | 2003 | 5 |
| 19 | 1998 | 22 | |
| 20 | 1997 | 19 |
About Yoshihiro Hatta
Yoshihiro Hatta is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 159 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (38 papers), Acute Myeloid Leukemia Research (29 papers), Acute Lymphoblastic Leukemia research (27 papers), Chronic Lymphocytic Leukemia Research (25 papers), Lymphoma Diagnosis and Treatment (23 papers), Eosinophilic Disorders and Syndromes (19 papers), T-cell and Retrovirus Studies (14 papers) and Retinoids in leukemia and cellular processes (10 papers). The work is most often cited by research in Hematology (654 citations), Genetics (367 citations) and Oncology (848 citations). Yoshihiro Hatta has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include HP Koeffler, Noriyoshi Iriyama, Masao Tomonaga, Seisho Takeuchi, Jin Takeuchi, Carl W. Miller, Roberta Morosetti, Toshiyasu Hirama, Norihiko Kawamata and Yohei Yamada. Their work appears in journals such as Blood, International Journal of Hematology, British Journal of Haematology, Leukemia Research and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.